 |
Drug Development and Drug
Interactions: Presentations
2008
- "Drug Interactions and Labeling - Issues Beyond the Font Size" [PDF]
Huang, S-M
9th International Workshop, Clinical Pharmacology of HIV Therapy, April 8, 2008,
New Orleans, LA
- "Evaluation and Labeling of Drug-Drug Interactions - Focusing on Transporters" [PDF]
Huang, S-M
FDA Critical Path Transporter Workshop, October 3, 2008
- "When to Conduct a Renal Impairment Study" [PDF]
Huang, S-M
Clinical Pharmacology Advisory Committee Meeting,
March 19, 2008, Rockville, MD
2007
- "Drug Interactions & Labeling- Issues Beyond the Font Size" [PDF]
Huang, S-M
UCSF/AAPS- Dr. Les Benet Symposium
The Impact of Pharmacokinetics in Modern Drug Development—10 Years Later, November 16, 2007, San Francisco, CA
- "FDA Critical Path Initiatives: Opportunities for Drug Development, Regulatory Review and Clinical Practice" [PDF]
November 14, 2007
Huang, S-M
AAPS Annual meeting,
Hot Topics Discussion, November 14, 2007,
San Diego, CA
- "Making a Decision on Drug Metabolism Data: Go or No Go Human-specific Metabolites -Regulatory Perspective" [PDF]
Huang, S-M
AAPS Pharmacokinetics, Pharmacodynamics and Drug Metabolism,
November 12, 2007, San Diego, CA
- "Enzyme- and Transporter-Based Drug Interactions: Progress and Future Challenges: Regulatory Aspect of Drug-Drug Interactions" [PDF]
Huang, S-M
AAPS/ISSX Workshop,
Satellite Program of 2007 AAPS Annual Meeting,
November 10, 2007, San Diego, CA
2006
- "FDA Perspectives on Drug Transporters and Their Role in Drug Interactions" [PDF]
Haung, S-M
EUFEPS Conference on Membrane Drug Transporters: Impact on Drug Discovery, Development, Regulation and Usuage, September 25, 2006, Copenhagen, Denmark
- "Risk of Drug Interactions involving Herbal and Citrus Products"
[PDF]
Huang, S-M
Health Canada International Symposium on Drug, Food, and Natural Health Product Interactions
February 9, 2006, Gatineau, Quebec.
2005
- "Drug -Natural Product Interactions-Labeling Implications" [PDF]
Huang, S-M
AAPS Annual Meeting, November 10, 2005, Nashville, TN.
- "Drug Interaction Studies — Study Design, Data Analysis, and
Implications for Dosing and Labeling: Current Opinion"
[HTML] [PDF]
Huang, S-M, Reynolds KS, Strong JM, Nallani S, Lesko LJ, Temple R, Abraham S, Alhabet S,
Baweja R, Chung S, Colangelo P, Collins J, Frucht D, Green MD,
Hepp P, Kavanagh R, Ko HS, Marroum P, Norden J, Qiu W, Rahman A,
Sobel S, Stifano T, Wei X, Yasuda S, Zhang L, Zheng JH
FDA Science Forum, April 26-28, 2005, Washington D.C.
- "An FDA View of Drug Transporters and What Can Be Included in a Submission"
[PDF]
Huang, S-M
AAPS Transporter Workshop, March 8 2005, Parsippany, NJ
- "Dose dependent inhibition of midazolam elimination by ketoconazole: effect of CYP3A5 genotype"
[HTML]
A. Lucksiri A, Vuppalanchi R, Hilligoss JK, Hamman MA, Li L, Chien JY, Huang S-M, Hall SD,
FDA Science Forum, April 26-28, 2005, Washington DC.
- "Clinical trials and drug interactions" [PDF]
Huang S-M
Clinical pharmacology review course at the Annual Meeting of American Society
of Clinical Pharmacology and Therapeutics (ASCPT) meeting, March 6, 2005, Orlando, Florida
2004
- "FDA’s perspective on the Use of Hepatocytes in in vitro Assays
to Support Regulatory Applications, Pre-meeting workshop"
Huang, S-M
ISSX, August 28, 2004, Vancouver, Canada
- "Update on Drug Metabolism/Drug Interaction Studies —
Study Design, Data Analysis, and Implications for Dosing and Labeling"
[PDF]
Huang, S-M
HepatocyteResearch Association Satellite Meeting to 7th
ISSX August 28, 2004, Vancouver, Canada
2003
- "Gender Differences in Drug Response: Metabolism and Transport Differences- How Much Do We Know?"
[PDF]
Huang, S-M
Sex and Rx, A Symposium on Women and Medicine, [external
link] October 24, 2003, Baltimore, MD.
- "Drug interactions, or lack of drug interaction? What should we
care about in terns of BA, BE, PK?"
Huang, S-M
Bio-International Meeting, October 7-10, 2003, London, UK
- "Effect of pharmacogenetics and drug-drug interactions on
exposure-response: what needs to be done?"
Huang, S-M
32nd Annual meeting of American College of Clinical Pharmacology, September 21, 2003, Tampa, FL
- "Exposure-Response (E-R) Relationships- From Research to Clinic:
Adjusting Dosage Regimens to Manage Risks"
Huang, S-M
32nd Annual meeting of American College of Clinical Pharmacology, September 21, 2003, Tampa, FL
- "Risk of drug interactions involving herbal/other products"
Huang, S-M
32rd Annual meeting of American College of Clinical Pharmacology, September 21, 2003, Tampa, FL
- "Risk of drug-herb and drug-citrus fruit interactions"
Huang, S-M
Institute of Food and Technology: Herb and grapefruit juice-drug interactions, July
12-16, 2003, Chicago, IL
- "When is drug interaction an issue? How much data do we need for an informed labeling?"
Huang, S-M
Drug Information Association meeting, June 16-19, 2003, San Antonio, TX.
- "The effect of pregnancy on pharmacokinetics- how much do we know?"
Huang, S-M
Drug Information Association meeting, June 16-19, 2003, San Antonio, TX
Back
to Top 
Back to Drug Interactions
 PDF requires the free Adobe
Acrobat Reader
Date created: October 3, 2006, Updated October 3, 2008 |
|
